AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35091136 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing intervention
Number of subjects: 236
Study 35091136 — intervention group
Group type: COMPARATOR
Intervention: Educational control
Number of subjects: 236
Study 34127645 — intervention group
Group type: EXPERIMENTAL
Intervention: Jackfruit365™ green jackfruit flour 30 g/day (Group A)
Number of subjects: 40
Study 34127645 — intervention group
Group type: COMPARATOR
Intervention: Placebo flour (Group B)
Number of subjects: 40
Study 33451962 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine infusion (20 mg bolus followed by 5 μg/kg/min infusion)
Number of subjects: 54
Study 33451962 — intervention group
Group type: COMPARATOR
Intervention: Narcotic-only control (100 μg fentanyl with additional fentanyl and 0.3 mg hydromorphone)
Number of subjects: 54
Study 36316835 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 81
Study 36316835 — intervention group
Group type: COMPARATOR
Intervention: Desflurane
Number of subjects: 81
Study 36316835 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Sevoflurane and Desflurane
Number of subjects: 81
Study 35197374 — intervention group
Group type: EXPERIMENTAL
Intervention: NanoCare Gold
Number of subjects: 19
Study 35197374 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine
Number of subjects: 19
Study 35197374 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 19
Study 32160948 — intervention group
Group type: EXPERIMENTAL
Intervention: RV3-BB rotavirus vaccine (neonatal schedule, first dose at 0-5 days of age)
Number of subjects: 196
Study 32160948 — intervention group
Group type: EXPERIMENTAL
Intervention: RV3-BB rotavirus vaccine (infant schedule, first dose at 8 weeks of age)
Number of subjects: 196
Study 32160948 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 196
Study 34187468 — intervention group
Group type: EXPERIMENTAL
Intervention: Phone-based recruitment
Number of subjects: 1068
Study 34187468 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person recruitment
Number of subjects: 1068
Study 34187468 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall recruitment strategies
Number of subjects: 1068
Study 36056407 — intervention group
Group type: EXPERIMENTAL
Intervention: PEER intervention added to service as usual (SAU)
Number of subjects: 284
Study 36056407 — intervention group
Group type: COMPARATOR
Intervention: SAU alone
Number of subjects: 284
Study 36056407 — intervention group
Group type: EXPERIMENTAL
Intervention: PEER intervention added to SAU
Number of subjects: 284
Study 32770394 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cancer Recovery (MBCR)
Number of subjects: 77
Study 32770394 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 77
Study 35657651 — intervention group
Group type: EXPERIMENTAL
Intervention: OROS-methylphenidate
Number of subjects: 0
Study 35657651 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33357606 — intervention group
Group type: EXPERIMENTAL
Intervention: MedMinder 'Jon' electronic pillbox
Number of subjects: 25
Study 33357606 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (control condition)
Number of subjects: 25
Study 33357606 — intervention group
Group type: EXPERIMENTAL
Intervention: Pillbox alerts
Number of subjects: 25
Study 32739537 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate complete revascularization (experimental arm)
Number of subjects: 1525
Study 32739537 — intervention group
Group type: COMPARATOR
Intervention: Culprit-only plus staged complete revascularization (control arm)
Number of subjects: 1525
Study 33735670 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled levosimendan (LS)
Number of subjects: 50
Study 33735670 — intervention group
Group type: COMPARATOR
Intervention: Intravenous levosimendan (LS)
Number of subjects: 50
Study 32569102 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily 30-minute massage for 7 consecutive days
Number of subjects: 60
Study 32569102 — intervention group
Group type: COMPARATOR
Intervention: Daily 30-minute restriction of non-essential caregiving (Quiet Time) for 7 consecutive days
Number of subjects: 60
Study 33450972 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-operative compression stockings and individualized exercise education (Intervention Group)
Number of subjects: 51
Study 33450972 — intervention group
Group type: COMPARATOR
Intervention: Education on lymphedema risk-reduction alone (Control Group)
Number of subjects: 51
Study 33006562 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-way SMS text messaging
Number of subjects: 232
Study 33006562 — intervention group
Group type: COMPARATOR
Intervention: One-way SMS text messaging
Number of subjects: 232
Study 34973853 — intervention group
Group type: EXPERIMENTAL
Intervention: burn+glutamine (B+G)
Number of subjects: 55
Study 34973853 — intervention group
Group type: COMPARATOR
Intervention: burn control (B)
Number of subjects: 55
Study 34187394 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine/indomethacin combination therapy
Number of subjects: 117
Study 34187394 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine monotherapy
Number of subjects: 117
Study 33527395 — intervention group
Group type: EXPERIMENTAL
Intervention: Eperisone 50 mg (Murex®)
Number of subjects: 15
Study 33527395 — intervention group
Group type: EXPERIMENTAL
Intervention: Population PK modeling
Number of subjects: 15
Study 33527395 — intervention group
Group type: EXPERIMENTAL
Intervention: Covariate analysis
Number of subjects: 15
Study 33218498 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive verbal input (n=25)
Number of subjects: 75
Study 33218498 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative verbal input (n=25)
Number of subjects: 75
Study 33218498 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=25)
Number of subjects: 75
Study 616886746 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese medicine-based nursing care
Number of subjects: 95
Study 34306274 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidimensional treatment (MT) group, n = 30
Number of subjects: 60
Study 34306274 — intervention group
Group type: COMPARATOR
Intervention: Unimodal treatment (UT) group, n = 30
Number of subjects: 60
Study 35352373 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluten (10 g in two granola bars for 7 days)
Number of subjects: 33
Study 35352373 — intervention group
Group type: COMPARATOR
Intervention: Placebo (two granola bars without gluten for 7 days)
Number of subjects: 33
Study 35352373 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluten
Number of subjects: 33
Study 35352373 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 34292562 — intervention group
Group type: EXPERIMENTAL
Intervention: Protamine sulfate (PS)
Number of subjects: 100
Study 34292562 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 100
Study 32244279 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivitamins (containing 50 µg vitamin B12)
Number of subjects: 491
Study 32244279 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 491
Study 34678466 — intervention group
Group type: EXPERIMENTAL
Intervention: iDBT-Pain intervention (four weeks of online DBT skills training with one-on-one sessions over Zoom and a web app)
Number of subjects: 3
Study 34678466 — intervention group
Group type: EXPERIMENTAL
Intervention: iDBT-Pain intervention
Number of subjects: 3
Study 33971824 — intervention group
Group type: EXPERIMENTAL
Intervention: Second forward-view examination (SFE)
Number of subjects: 392
Study 32650886 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational pain management program
Number of subjects: 200
Study 32650886 — intervention group
Group type: COMPARATOR
Intervention: Control group (no educational intervention)
Number of subjects: 200
Study 35763357 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan 0.1 mcg/kg/min from anesthetic induction
Number of subjects: 19
Study 35763357 — intervention group
Group type: COMPARATOR
Intervention: Milrinone 0.5 mcg/kg/min (control)
Number of subjects: 19
Study 34417064 — intervention group
Group type: EXPERIMENTAL
Intervention: Graphic narrative informed consent
Number of subjects: 59
Study 34417064 — intervention group
Group type: COMPARATOR
Intervention: Standard informed consent
Number of subjects: 59
Study 34417064 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 59
Study 32710888 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramadan intermittent fasting (RIF) for 30 days
Number of subjects: 28
Study 32710888 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) with normal daily habits
Number of subjects: 28
Study 32710888 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (EG) after RIF
Number of subjects: 28
Study 34704121 — intervention group
Group type: EXPERIMENTAL
Intervention: Safflower oil (SAF)
Number of subjects: 16
Study 34704121 — intervention group
Group type: EXPERIMENTAL
Intervention: Palm oil (PAL)
Number of subjects: 16
Study 34704121 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (VCL)
Number of subjects: 16
Study 34649590 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 weekly sessions of virtually delivered qualified exercise professional (QEP) support
Number of subjects: 108
Study 34649590 — intervention group
Group type: COMPARATOR
Intervention: Control group without QEP support
Number of subjects: 108
Study 34649590 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 weekly sessions of virtually delivered QEP support
Number of subjects: 108
Study 35604689 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard‐plus (timing and coordination training)
Number of subjects: 249
Study 35604689 — intervention group
Group type: COMPARATOR
Intervention: Standard strength and endurance training
Number of subjects: 249
Study 34659642 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic oxidative stress score (SOS) based on five biomarkers: serum creatinine (CRE), serum albumin (ALB), total bilirubin (TBIL), lactate dehydrogenase (LDH), and blood urea nitrogen (BUN)
Number of subjects: 1583
Study 34659642 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram based on SOS and clinical characteristics
Number of subjects: 1583
Study 36781628 — intervention group
Group type: EXPERIMENTAL
Intervention: Discrete Choice Experiment
Number of subjects: 140
Study 36781628 — intervention group
Group type: COMPARATOR
Intervention: BWS-2
Number of subjects: 140
Study 34275240 — intervention group
Group type: EXPERIMENTAL
Intervention: Video distraction
Number of subjects: 80
Study 34275240 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80
Study 34776340 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary fiber intake
Number of subjects: 68
Study 34776340 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy plant-based diet index
Number of subjects: 68
Study 34776340 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher protein-to-fiber ratio
Number of subjects: 68
Study 34776340 — intervention group
Group type: EXPERIMENTAL
Intervention: Intake of vegetables and whole grains
Number of subjects: 68
Study 34776340 — intervention group
Group type: EXPERIMENTAL
Intervention: Unclassified Prevotella species
Number of subjects: 68
Study 32458093 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced super-mini-PCNL (eSMP)
Number of subjects: 100
Study 32458093 — intervention group
Group type: COMPARATOR
Intervention: Conventional Chinese mini‐PCNL (mPCNL)
Number of subjects: 100
Study 35253730 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS (frequency 100 Hz, burst-rate 2 Hz, burst-width 150 μs, intensity 40 mA, duration 30 min)
Number of subjects: 62
Study 35253730 — intervention group
Group type: COMPARATOR
Intervention: Sham-TENS
Number of subjects: 62
Study 33151934 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Support (BS)
Number of subjects: 113
Study 33151934 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Support + Shopping Feedback (SF)
Number of subjects: 113
Study 33151934 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 113
Study 36383848 — intervention group
Group type: EXPERIMENTAL
Intervention: Happy Child Program (PCF)
Number of subjects: 3242
Study 36383848 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 3242
Study 32291982 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous injection of 1.0 g TXA before operation (Group B)
Number of subjects: 45
Study 32291982 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous injection of 1.0 g TXA before operation combined with local use of TXA cocktail during operation (Group C)
Number of subjects: 45
Study 32291982 — intervention group
Group type: COMPARATOR
Intervention: No TXA administered (Group A)
Number of subjects: 45
Study 36201815 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialogic reading with parents (PR-DR)
Number of subjects: 850
Study 36201815 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialogic reading with siblings (SR-DR)
Number of subjects: 850
Study 36201815 — intervention group
Group type: COMPARATOR
Intervention: Parent reading control (PR-C)
Number of subjects: 850
Study 36201815 — intervention group
Group type: COMPARATOR
Intervention: Sibling reading control (SR-C)
Number of subjects: 850
Study 33159536 — intervention group
Group type: EXPERIMENTAL
Intervention: Air pyelogram
Number of subjects: 122
Study 33159536 — intervention group
Group type: COMPARATOR
Intervention: Contrast pyelogram
Number of subjects: 122
Study 35436844 — intervention group
Group type: EXPERIMENTAL
Intervention: CTB group
Number of subjects: 70
Study 35436844 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 70
Study 33653410 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion regulation training (eight 90-min sessions, one session weekly)
Number of subjects: 70
Study 33653410 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 70
Study 36088189 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 175
Study 36088189 — intervention group
Group type: COMPARATOR
Intervention: HF self-care education
Number of subjects: 175
Study 34670026 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep Brain Stimulation (DBS) of the ventral capsule/ventral striatum (VC/VS)
Number of subjects: 8
Study 34670026 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep Brain Stimulation (DBS)
Number of subjects: 8
Study 36457115 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic surgery plus hybrid CO2 HIPEC system
Number of subjects: 0
Study 36457115 — intervention group
Group type: COMPARATOR
Intervention: Standard surgery
Number of subjects: 0
Study 34288699 — intervention group
Group type: EXPERIMENTAL
Intervention: 177Lu-DOTATATE plus radiosensitizing capecitabine
Number of subjects: 76
Study 34288699 — intervention group
Group type: COMPARATOR
Intervention: Octreotide long-acting release (LAR)
Number of subjects: 76
Study 35377998 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic mouthwash
Number of subjects: 25
Study 35377998 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 32591421 — intervention group
Group type: EXPERIMENTAL
Intervention: Fructose (20 g) intake 30 minutes prior to exercise
Number of subjects: 14
Study 32591421 — intervention group
Group type: COMPARATOR
Intervention: Control (no fructose intake)
Number of subjects: 14
Study 70706386 — intervention group
Group type: EXPERIMENTAL
Intervention: Early debridement of one side of the nose postoperatively.
Number of subjects: 0
Study 70706386 — intervention group
Group type: COMPARATOR
Intervention: Control side (no debridement).
Number of subjects: 0
Study 70706386 — intervention group
Group type: EXPERIMENTAL
Intervention: Debridement (removal of crusting).
Number of subjects: 0
Study 36498598 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional stented group (CSG)
Number of subjects: 104
Study 36498598 — intervention group
Group type: COMPARATOR
Intervention: Nonstented group (NSG)
Number of subjects: 104
Study 33160147 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen with reported hot flushes
Number of subjects: 0
Study 33160147 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen with reported hot flushes in postmenopausal women
Number of subjects: 0
Study 33160147 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen with gynaecological side effects
Number of subjects: 0
Study 35469517 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care plus the ISP team (intervention group)
Number of subjects: 58
Study 35469517 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 58
Study 34911175 — intervention group
Group type: EXPERIMENTAL
Intervention: Delphi technique for ASA classification
Number of subjects: 37
Study 35522900 — intervention group
Group type: EXPERIMENTAL
Intervention: ATx201 OINTMENT 2%
Number of subjects: 36
Study 35522900 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (placebo)
Number of subjects: 36
Study 32281943 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritionist Buddy (nBuddy) mobile app + dietary and lifestyle advice by a dietitian
Number of subjects: 108
Study 32281943 — intervention group
Group type: COMPARATOR
Intervention: Standard care (dietary and lifestyle advice by a trained nurse)
Number of subjects: 108
Study 32605633 — intervention group
Group type: EXPERIMENTAL
Intervention: Frozen embryo transfer
Number of subjects: 0
Study 32605633 — intervention group
Group type: COMPARATOR
Intervention: Fresh embryo transfer
Number of subjects: 0
Study 33290097 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized cognitive training applications (CCTA)
Number of subjects: 32
Study 33290097 — intervention group
Group type: COMPARATOR
Intervention: Placebo-control group
Number of subjects: 32
Study 33393175 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin (BT) injection
Number of subjects: 24
Study 33393175 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 33830090 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported flare (SRF)
Number of subjects: 126
Study 33830090 — intervention group
Group type: COMPARATOR
Intervention: Greater than average pain (PDF)
Number of subjects: 126
Study 33830090 — intervention group
Group type: EXPERIMENTAL
Intervention: SRF+PDF
Number of subjects: 126
Study 33830090 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy at work and during leisure activities
Number of subjects: 126
Study 32141095 — intervention group
Group type: EXPERIMENTAL
Intervention: Corrected estimator of sensitive population proportion
Number of subjects: 0
Study 32141095 — intervention group
Group type: COMPARATOR
Intervention: Greenberg et al.'s estimator
Number of subjects: 0
Study 32699918 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin
Number of subjects: 52
Study 32699918 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 52
Study 33317621 — intervention group
Group type: EXPERIMENTAL
Intervention: MSI-195 (400, 800, and 1600 mg)
Number of subjects: 34
Study 33317621 — intervention group
Group type: EXPERIMENTAL
Intervention: MSI-195
Number of subjects: 34
Study 33317621 — intervention group
Group type: COMPARATOR
Intervention: SAM-e Complete™
Number of subjects: 34
Study 36455422 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyspnea Challenge in HF
Number of subjects: 46
Study 36455422 — intervention group
Group type: COMPARATOR
Intervention: Dyspnea Challenge in COPD
Number of subjects: 46
Study 34403486 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine cloths
Number of subjects: 0
Study 37013278 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 1mg/kg
Number of subjects: 80
Study 37013278 — intervention group
Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 80
Study 33505516 — intervention group
Group type: EXPERIMENTAL
Intervention: iT3SE-PX method using protein sequences and features from PSSM profiles
Number of subjects: 0
Study 33505516 — intervention group
Group type: EXPERIMENTAL
Intervention: Extreme gradient boosting (XGBoost) algorithm for feature ranking
Number of subjects: 0
Study 33505516 — intervention group
Group type: EXPERIMENTAL
Intervention: Support vector machine (SVM) classifier for prediction
Number of subjects: 0
Study 32852421 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzocaine
Number of subjects: 48
Study 32852421 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine alone
Number of subjects: 48
Study 32852421 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine and prilocaine mixture
Number of subjects: 48
Study 32852421 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 48
Study 35463794 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based online supervised exercise program (HOSEP)
Number of subjects: 100
Study 35463794 — intervention group
Group type: COMPARATOR
Intervention: Conventional health education with a home exercise program booklet
Number of subjects: 100
Study 32506228 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% triamcinolone acetonide dental paste
Number of subjects: 40
Study 32506228 — intervention group
Group type: EXPERIMENTAL
Intervention: S. salivarius K12 lozenge
Number of subjects: 40
Study 32506228 — intervention group
Group type: COMPARATOR
Intervention: S. salivarius ATCC® BAA‐2593™ supernatants
Number of subjects: 40
Study 32506228 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy individuals)
Number of subjects: 40
Study 33417903 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized two-player linear games with fluctuating payoffs
Number of subjects: 0
Study 33417903 — intervention group
Group type: EXPERIMENTAL
Intervention: Prisoner's Dilemma with independent payoffs
Number of subjects: 0
Study 33417903 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing mutation rate
Number of subjects: 0
Study 34514495 — intervention group
Group type: EXPERIMENTAL
Intervention: Free diet and single donor standard faecal transplantation (FT) by colonoscopy on Day 1 and rectal enemas on Days 2 and 14 without dietary conditioning of the donor.
Number of subjects: 62
Study 34514495 — intervention group
Group type: EXPERIMENTAL
Intervention: Faecal transplantation (FT) with dietary pre-conditioning of the donor for 14 days and a UC Exclusion Diet (UCED) for the patients.
Number of subjects: 62
Study 34514495 — intervention group
Group type: COMPARATOR
Intervention: UC Exclusion Diet (UCED) alone.
Number of subjects: 62